Inventor · disambiguated record
Anthony Ivetac
Also filed as: IVETAC ANTHONY
11 granted patents·9 pending applications·15 citations·filing 2014–2025
85Inventor score
Top patents by PatentIndex Score
20 records- 0192US12421253B2Tetrahydropyridopyrimidine pan-KRas inhibitorsMIRATI THERAPEUTICS INC·Filed 2024·Granted Sep 23, 2025·1 cites·29 claims
- 0289US11999753B2Tetrahydropyridopyrimidine pan-KRas inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Granted Jun 4, 2024·1 cites·5 claims
- 0386US9040522B26-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHDTAKEDA PHARMACEUTICAL·Filed 2014·Granted May 26, 2015·7 cites·10 claims
- 0484US11479551B2MTA-cooperative PRMT5 inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Oct 25, 2022·1 cites·30 claims
- 0582US9345713B26-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHDTAKEDA PHARMACEUTICAL·Filed 2015·Granted May 24, 2016·3 cites·10 claims
- 0679US9708296B26-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHDTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jul 18, 2017·2 cites·8 claims
- 0777US12304915B2SOS1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Granted May 20, 2025·0 cites·81 claims
- 0875US2025270220A1Sos1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0972US2023054883A1MTA-Cooperative PRMT5 InhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1068US11492351B2MTA-cooperative PRMT5 inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Nov 8, 2022·0 cites·27 claims
- 1167US11702418B2SOS1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Jul 18, 2023·0 cites·72 claims
- 1266US2025382290A1Salts of sos1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1364US2025368649A1Tetrahydropyridopyrimidine pan-kras inhibitorsMIRATI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1464US2024025907A1QUINAZOLINE PAN-KRas INHIBITORSMIRATI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1562US9944626B26-(5-hydroxy-1H-pyrazol-1-YL)nicotinamide inhibitors of PHDTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Apr 17, 2018·0 cites·7 claims
- 1660US10407409B26-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHDTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Sep 10, 2019·0 cites·2 claims
- 1759US2024368153A1Aminopyridine-based MTA-Cooperative PRMT5 InhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1859US2025059182A1Sos1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1957US2024208912A1MTA-Cooperative PRMT5 InhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2055US2023312482A1Sos1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anthony Ivetac files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →